- Home
- BDTX vs ACR Comparison
BDTX vs ACR Comparison
Compare BDTX & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDTX | ACR |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | 4 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.1M | 139.5M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | BDTX | ACR |
|---|---|---|
| Price | $2.48 | $18.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $10.40 | ★ $24.50 |
| AVG Volume (30 Days) | ★ 903.9K | 23.3K |
| Earning Date | 03-05-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.65 |
| EPS | 0.38 | ★ 0.95 |
| Revenue | $70,000,000.00 | ★ $88,952,000.00 |
| Revenue This Year | N/A | $3.67 |
| Revenue Next Year | N/A | $1.87 |
| P/E Ratio | ★ $6.59 | $20.08 |
| Revenue Growth | N/A | ★ 14.87 |
| 52 Week Low | $1.20 | $16.51 |
| 52 Week High | $4.94 | $24.61 |
Technical Indicators
Market Signals| Indicator | BDTX | ACR |
|---|---|---|
| Relative Strength Index (RSI) | 40.70 | 33.88 |
| Support Level | $2.49 | $18.64 |
| Resistance Level | $2.70 | $19.52 |
| Average True Range (ATR) | 0.15 | 0.54 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 24.47 | 25.00 |
Price Performance
Historical ComparisonAbout BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.